NCT06501560

Brief Summary

This study is a series of descriptive-analytic studies on genomic variants in the facial skin of patients with AV at the Dermatology and Venereology Polyclinic by determining the genetic profile by GWAS examination in AVB and analysing the genetic profile in AVB against differences in geographical location. The research design used was a cross-sectional design.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 2, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 15, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 17, 2024

Completed
Last Updated

July 15, 2024

Status Verified

July 1, 2024

Enrollment Period

2 months

First QC Date

June 2, 2024

Last Update Submit

July 9, 2024

Conditions

Keywords

AcneAcne Vulgaris (AV)Genome Wide Association Study (GWAS)GeneticGenotypeDeoxyribonucleic Acid (DNA)Single Nucleotide Polymorphism (SNP)

Outcome Measures

Primary Outcomes (7)

  • Severity of acne vulgaris

    Physical examination: identify the number of blackheads, papules, pustules and cysts. Degree of severity:(1)Mild =Comedo\<20, or inflammatory lesion\<15, or total lesion\<30(2)Moderate = Comedo 20-100, or inflammatory lesion15-50, or total lesion 30-125(3)Severe =cyst\>5, or Comedo\>100, or inflammatory lesion\>50, or total lesion\>125.

    1 year

  • Population structure

    Gene testing of blood sample Genetic Inflation Factor (GIF) \>1.1 or \<1.1 Principal Component Analysis (PCA)

    3 months

  • Genomic Profile

    Blood sample examination, processed using GWAS Mutations (SNPs)(1)Present(2)Absent

    3 months

  • Linkage disequilibirium (LD)

    Gene testing of blood samples Coefficient 0-1

    3 months

  • Haplotype

    Gene testing of blood samples Jumlah gen 1. Satu gen 2. Multipel gen

    3 months

  • SNP Enrichment

    Gene testing of blood samples Mutation position

    3 months

  • Association analysis and Association analysis of imputation results

    Gene testing of blood samples PCA value

    3 months

Study Arms (2)

Lifestyle counseling

EXPERIMENTAL
Genetic: GWAS

clinical examination

EXPERIMENTAL
Genetic: GWAS

Interventions

GWASGENETIC

In GWAS studies, data are collected to determine common variants in a number of individuals, either with or without a common trait (for example,. disease) across the genome, using genome wide SNP arrays.

Lifestyle counselingclinical examination

Eligibility Criteria

Age17 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Males or females with AVB aged 17-21 years
  • Both parents of complete subjects with or without a history of acne vulgaris aged up to 60 years
  • Patients and parents are willing to participate in the study and sign informed consent.

You may not qualify if:

  • Patients who have other inflammatory or infectious diseases especially on the face
  • Have genetic diseases or disorders
  • Diagnosed with primary or secondary immunodeficiency diseases
  • Using oral or systemic antibiotic, anti-inflammatory, retinoid or hormone therapy in the past month.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitas Indonesia

Jakarta Pusat, Jakarta Special Capital Region, 10430, Indonesia

RECRUITING

MeSH Terms

Conditions

Acne Vulgaris

Condition Hierarchy (Ancestors)

Acneiform EruptionsSkin DiseasesSkin and Connective Tissue DiseasesSebaceous Gland Diseases

Central Study Contacts

Irma Bernadette, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr. dr. Irma Bernadette S. Sitohang, Sp.KK (K)

Study Record Dates

First Submitted

June 2, 2024

First Posted

July 15, 2024

Study Start

October 1, 2023

Primary Completion

November 30, 2023

Study Completion

August 17, 2024

Last Updated

July 15, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

The results of this study are expected to be the initial stage for further research on genetic profiles in AVB, Benefits for the Field of Community Service-Improve clinician knowledge about genetic profiles in AVB-The results of this study are expected to be used as a reference in acne vulgaris management services so that they can produce more measurable and effective therapy. and provide a positive impact for RSCM to improve optimal service to Dermatology and Venereology patients.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
1 year
Access Criteria
data collection

Locations